Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Industry Faces GPO, Reform Challenges In Germany - Survey Predicts

This article was originally published in The Gray Sheet

Executive Summary

German hospitals see as many as 90% of their number as part of group purchasing organizations within the next three years, increasing medical technology pricing pressures in the German market, according to a survey of the German hospital sector by Munich-based Roland Berger & Partners GmbH.

You may also be interested in...



Baxter Cardiovascular Business To Boost R&D Spending After Spin-Off

The soon-to-be independent Baxter Cardiovascular Group's R&D spending is expected to increase by 50% over the current coporate rate of 6%.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel